111 related articles for article (PubMed ID: 8343271)
1. Evidence for bimodal distribution of breast carcinoma ER and PgR values quantitated by enzyme immunoassay.
Mobbs BG; Chapman JA; Sutherland DJ; Ryan E; Tustanoff ER; Ooi TC; Murthy PV
Eur J Cancer; 1993; 29A(9):1293-7. PubMed ID: 8343271
[TBL] [Abstract][Full Text] [Related]
2. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical and biochemical analysis of the oestrogen regulated protein pS2, and its relation with oestrogen receptor and progesterone receptor in breast cancer.
Detre S; King N; Salter J; MacLennan K; McKinna JA; Dowsett M
J Clin Pathol; 1994 Mar; 47(3):240-4. PubMed ID: 8163696
[TBL] [Abstract][Full Text] [Related]
4. An investigation of cut-points for primary breast cancer oestrogen and progesterone receptor assays.
Chapman JW; Mobbs BG; McCready DR; Lickley HL; Trudeau ME; Hanna W; Kahn HJ; Sawka CA; Fish EB; Pritchard KI
J Steroid Biochem Mol Biol; 1996 Mar; 57(5-6):323-8. PubMed ID: 8639468
[TBL] [Abstract][Full Text] [Related]
5. Estrogen & progesterone receptors measurement in breast cancer with enzyme-immunoassay & correlation with other prognostic factors.
Redkar AA; Kabre SS; Mittra I
Indian J Med Res; 1992 Feb; 96():1-8. PubMed ID: 1597324
[TBL] [Abstract][Full Text] [Related]
6. Steroid receptor measurement in breast cancers: comparison between ligand binding and enzyme-immunoassay in cytosolic and nuclear extracts.
Luqmani YA; Temmim L; Memon A; Ali MA; Parkar AH
Int J Cancer; 1997 May; 71(4):526-38. PubMed ID: 9178804
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols.
Foekens JA; Portengen H; van Putten WL; Peters HA; Krijnen HL; Alexieva-Figusch J; Klijn JG
Cancer Res; 1989 Nov; 49(21):5823-8. PubMed ID: 2676151
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and methodological considerations in the quantification of estrogen and progesterone receptors using monoclonal antibodies in breast cancer].
Navarro MA; Huguet J; Valero J; Samaniego JM; Rosel P; Sirvent JJ
Med Clin (Barc); 1991 Jun; 97(2):41-4. PubMed ID: 1895780
[TBL] [Abstract][Full Text] [Related]
9. [Inconsistency in quantitation of estrogen receptor and progesterone receptor with dextran charcoal method and enzyme immunoassay].
Morimoto K; Hasuma T; Koh M; Ohtani S; Kinoshita H
Gan To Kagaku Ryoho; 2002 Sep; 29(9):1597-605. PubMed ID: 12355945
[TBL] [Abstract][Full Text] [Related]
10. [Receptor status (ER and PgR) determined with histochemical and biochemical methods in breast carcinoma].
Simone G; Paradiso A; Cirillo R; Mangia A; Rella G; Wiesel S; Petroni S; De Benedictis G; De Lena M
Pathologica; 1991; 83(1086):449-59. PubMed ID: 1724316
[TBL] [Abstract][Full Text] [Related]
11. Relationship between low estrogen receptor values and other prognostic factors in primary breast tumors.
Gaffney EV; Halpin DP; Blakemore WS
Surgery; 1995 Mar; 117(3):241-6. PubMed ID: 7878527
[TBL] [Abstract][Full Text] [Related]
12. Hormonal receptor determination of 1,052 Chinese breast cancers.
Chow LW; Ho P
J Surg Oncol; 2000 Nov; 75(3):172-5. PubMed ID: 11088048
[TBL] [Abstract][Full Text] [Related]
13. Steroid receptor distribution in 47,892 breast cancers. A collaborative study of 7 European laboratories. The EORTC Receptor Study Group.
Romain S; Lainé Bidron C; Martin PM; Magdelenat H
Eur J Cancer; 1995; 31A(3):411-7. PubMed ID: 7786610
[TBL] [Abstract][Full Text] [Related]
14. Comparison of new immunohistochemical assay for oestrogen receptor in paraffin wax embedded breast carcinoma tissue with quantitative enzyme immunoassay.
Saccani Jotti G; Johnston SR; Salter J; Detre S; Dowsett M
J Clin Pathol; 1994 Oct; 47(10):900-5. PubMed ID: 7962603
[TBL] [Abstract][Full Text] [Related]
15. Oestrogen receptor negative-progesterone receptor positive phenotype in 1,211 breast tumours.
Pichon MF; Milgrom E
Br J Cancer; 1992 Jun; 65(6):895-7. PubMed ID: 1616860
[TBL] [Abstract][Full Text] [Related]
16. [Expression of steroid receptors and DNA synthesis in male breast cancer].
Petroni S; Mangia A; D'Amico C; Simone G
Pathologica; 2003 Feb; 95(1):31-6. PubMed ID: 12735283
[TBL] [Abstract][Full Text] [Related]
17. Oestrogen receptor isoforms, their distribution and relation to progesterone receptor levels in breast cancer samples.
Baker VA; Puddefoot JR; Marsigliante S; Barker S; Goode AW; Vinson GP
Br J Cancer; 1992 Dec; 66(6):1083-7. PubMed ID: 1457348
[TBL] [Abstract][Full Text] [Related]
18. Intra- and inter-laboratory reproducibility of estrogen and progesterone receptor enzyme immunoassay in breast cancer cytosol samples--a Swedish multicenter study. Swedish Society of Cancer Study Group.
Fernö M; Bendahl PO; Brisfors A; Byman K; Ekeberg M; Ferraud L; Grankvist K; Hjalmers B; Nilsson A; Sellberg G; Skoog L; Stål O; Wingmo I
Acta Oncol; 1997; 36(8):793-8. PubMed ID: 9482684
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical determination of estrogen and progesterone receptors in breast cancer: relationship with clinicopathologic factors in 302 patients in Ivory Coast.
Effi AB; Aman NA; Koui BS; Koffi KD; Traoré ZC; Kouyate M
BMC Cancer; 2017 Feb; 17(1):115. PubMed ID: 28173783
[TBL] [Abstract][Full Text] [Related]
20. Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer.
Daffada AA; Johnston SR; Smith IE; Detre S; King N; Dowsett M
Cancer Res; 1995 Jan; 55(2):288-93. PubMed ID: 7812959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]